
Gene Matrix Announces Global Expansion and Upcoming Series A Funding Round for AI-Powered Genomics Platform
Global expansion drives $500M valuation for Gene Matrix. Prevents 30K+ adverse drug reactions yearly. US subscription launched. Series A opens soon. CHICAGO, IL, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- Gene Matrix Inc., a …